- STADA’s Philippine portfolio is being strengthened with FERN C, a well-established range of food supplements.
- STADA Philippines General Manager Sharmaine Abarientos: “With FERN C in our portfolio, we will establish a strong consumer healthcare platform to launch other quality medicines as well and provide better health for all Filipinos.”
- STADA CEO Peter Goldschmidt: “The acquisition of FERN will help us to execute our growth ambitions in the Philippines.”
- STADA Asia Pacific Managing Director Gary Clark: “With both STADA and FERN carrying heritage, we will be able to provide better health for Filipinos.“
After announcing a number of acquisitions and partnerships in Europe recently, the STADA Group is also expanding its portfolio in the Asia-Pacific region. As the global manufacturer of high-quality generic drugs and consumer healthcare products announced today, STADA is acquiring the FERN portfolio in the Philippines, one of the leading brands in the growing local Vitamin C market.The product range consists of FERN-C, a Vitamin C product that has been in the market for 15 years and FERN-C Kidz and Kiddimin – two products for the vitamin supply for children.
